208 related articles for article (PubMed ID: 38409029)
1. Treatment guidelines for rare, early-onset conditions associated with epileptic seizures: a literature review on Rett syndrome and tuberous sclerosis complex.
Amin S; Ruban-Fell B; Newell I; Evans J; Vyas K; Nortvedt C; Chin RF
Orphanet J Rare Dis; 2024 Feb; 19(1):89. PubMed ID: 38409029
[TBL] [Abstract][Full Text] [Related]
2. Treatment Guidelines for Rare, Early-Onset, Treatment-Resistant Epileptic Conditions: A Literature Review on Dravet Syndrome, Lennox-Gastaut Syndrome and CDKL5 Deficiency Disorder.
Chin RF; Mingorance A; Ruban-Fell B; Newell I; Evans J; Vyas K; Nortvedt C; Amin S
Front Neurol; 2021; 12():734612. PubMed ID: 34759881
[No Abstract] [Full Text] [Related]
3. Nordic treatment guidelines for rare epileptic conditions: A literature review.
Vyas K; Luedke H; Ruban-Fell B
Brain Behav; 2022 Jul; 12(7):e2622. PubMed ID: 35765698
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Prescription patterns of antiseizure drugs in tuberous sclerosis complex (TSC)-associated epilepsy: a multicenter cohort study from Germany and review of the literature.
Strzelczyk A; Grau J; Bast T; Bertsche A; Bettendorf U; Hahn A; Hartmann H; Hertzberg C; Hornemann F; Immisch I; Jacobs J; Klotz KA; Kluger G; Knake S; Knuf M; Kurlemann G; Marquard K; Mayer T; Meyer S; Muhle H; Müller-Schlüter K; von Podewils F; Rosenow F; Ruf S; Sauter M; Schäfer H; Schlump JU; Schubert-Bast S; Syrbe S; Thiels C; Trollmann R; Wiemer-Kruel A; Wilken B; Zukunft B; Zöllner JP
Expert Rev Clin Pharmacol; 2021 Jun; 14(6):749-760. PubMed ID: 33792454
[TBL] [Abstract][Full Text] [Related]
6. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
7. Management of epilepsy associated with tuberous sclerosis complex: Updated clinical recommendations.
Curatolo P; Nabbout R; Lagae L; Aronica E; Ferreira JC; Feucht M; Hertzberg C; Jansen AC; Jansen F; Kotulska K; Moavero R; O'Callaghan F; Papavasiliou A; Tzadok M; Jóźwiak S
Eur J Paediatr Neurol; 2018 Sep; 22(5):738-748. PubMed ID: 29880258
[TBL] [Abstract][Full Text] [Related]
8. Neurogenetic disorders and treatment of associated seizures.
Faulkner MA; Singh SP
Pharmacotherapy; 2013 Mar; 33(3):330-43. PubMed ID: 23400943
[TBL] [Abstract][Full Text] [Related]
9. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
Nevitt SJ; Sudell M; Weston J; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011412. PubMed ID: 28661008
[TBL] [Abstract][Full Text] [Related]
10. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
Nevitt SJ; Sudell M; Weston J; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011412. PubMed ID: 29243813
[TBL] [Abstract][Full Text] [Related]
11. Vigabatrin for Epileptic Spasms and Tonic Seizures in Tuberous Sclerosis Complex.
van der Poest Clement EA; Sahin M; Peters JM
J Child Neurol; 2018 Jul; 33(8):519-524. PubMed ID: 29687739
[TBL] [Abstract][Full Text] [Related]
12. Update on Drug Management of Refractory Epilepsy in Tuberous Sclerosis Complex.
van der Poest Clement E; Jansen FE; Braun KPJ; Peters JM
Paediatr Drugs; 2020 Feb; 22(1):73-84. PubMed ID: 31912454
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of vigabatrin in patients with tuberous sclerosis complex and infantile epileptic spasm syndrome: a systematic review.
Prezioso G; Chiarelli F; Matricardi S
Expert Rev Neurother; 2023; 23(7):661-671. PubMed ID: 37243682
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy for Seizures in Tuberous Sclerosis Complex.
Nabbout R; Kuchenbuch M; Chiron C; Curatolo P
CNS Drugs; 2021 Sep; 35(9):965-983. PubMed ID: 34417984
[TBL] [Abstract][Full Text] [Related]
15. The role of neurosurgery in the management of tuberous sclerosis complex-associated epilepsy: a systematic review.
Nie JZ; Karras CL; Trybula SJ; Texakalidis P; Alden TD
Neurosurg Focus; 2022 May; 52(5):E6. PubMed ID: 35535822
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin and rapalogs for tuberous sclerosis complex.
Sasongko TH; Ismail NF; Zabidi-Hussin Z
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD011272. PubMed ID: 27409709
[TBL] [Abstract][Full Text] [Related]
17. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
Nevitt SJ; Sudell M; Cividini S; Marson AG; Tudur Smith C
Cochrane Database Syst Rev; 2022 Apr; 4(4):CD011412. PubMed ID: 35363878
[TBL] [Abstract][Full Text] [Related]
18. Epileptic spasms in tuberous sclerosis complex.
Hsieh DT; Jennesson MM; Thiele EA
Epilepsy Res; 2013 Sep; 106(1-2):200-10. PubMed ID: 23796861
[TBL] [Abstract][Full Text] [Related]
19. Electro-clinical and neurodevelopmental outcome in six children with early diagnosis of tuberous sclerosis complex and role of the genetic background.
Savini MN; Mingarelli A; Peron A; La Briola F; Cervi F; Alfano RM; Canevini MP; Vignoli A
Ital J Pediatr; 2020 Mar; 46(1):36. PubMed ID: 32216820
[TBL] [Abstract][Full Text] [Related]
20. Epilepsy in children with tuberous sclerosis complex: Chance of remission and response to antiepileptic drugs.
Overwater IE; Bindels-de Heus K; Rietman AB; Ten Hoopen LW; Vergouwe Y; Moll HA; de Wit MC
Epilepsia; 2015 Aug; 56(8):1239-45. PubMed ID: 26046563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
